F. Hoffmann-La Roche Ltd and Foundation Medicine, Inc., or FMI, a molecular information company, have entered into a strategic collaboration to enhance the identification and development of novel treatment options for cancer patients. "We are very ... Individual.com, 6 days ago
Roche to acquire majority stake in Foundation Medicine for $1.3bn - Pharmaceutical Technology, 1 week ago
Roche invests $1.03bn to buy majority stake in Foundation Medicine - Pharmaceutical Business Review, 1 week ago
F. Hoffmann-La Roche Ltd has received the FDA approval for the cobas TaqScreen MPX test, v2.0, for use in the detection and identification of HIV, HCV, and HBV in donations of human whole blood and blood components including source plasma. This ...Individual.com, 1 week ago FDA approves Roche's blood screening assay for three viral targets detection Medical Devices Business Review, 2 weeks ago
F. Hoffmann-La Roche Ltd has announced results from a Phase III MARIANNE study, which evaluates three HER2-targeted regimens, Kadcyla plus Perjeta, Kadcyla alone, and Herceptin plus taxane chemotherapy, in people with previously untreated advanced ...Individual.com, 2 weeks ago
Study Findings on Enzymes and Coenzymes Are Outlined in Reports from F. Hoffmann-La Roche (Reaction Phenotyping: Advances in the Experimental...
Study Findings on Enzymes and Coenzymes Are Outlined in Reports from F. Hoffmann-La Roche (Reaction Phenotyping: Advances in the Experimental Strategies Used to Characterize the Contribution of Drug-Metabolizing Enzymes) By a News Reporter-Staff ...4 Traders, 2 weeks ago Study Findings from F. Hoffmann-La Roche Broaden Understanding of Xanthophylls (Effect of Compounds Affecting ABCA1 Expression and CETP Activity on... 4 Traders, 3 weeks ago
Switzerland-based Roche has signed an agreement to grant non-exclusive licenses to Qiagen for its recently provided patents pertaining to the detection of mutations in the EGFR pathway, including in the KRAS gene. Terms of the deal have not been ...Medical Devices Business Review, 1 week ago
Roche has entered into a license agreement with Meiji Seika Pharma (Meiji) and Fedora to develop and commercialize OP0595, a beta-lactamase inhibitor currently in Phase I clinical development. Beta-lactamase inhibitors are designed to restore or ...Pharmaceutical Business Review, 1 week ago Announcement of Signing of License Agreement regarding OP0595, a Beta-Lactamase Inhibitor PipelineReview, 1 week ago
Recently published research from Global Markets Direct, "Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014", is now available at Boston, MA -- (ReleaseWire) -- 01/26/2015 -- Global Markets Direct's, 'Gastroesophageal (GE) Junction ...Digital Journal, 9 hours ago Cirrhosis Therapeutics Clinical Trials Review H1 2015 Market Research Report Wall Street Select, 13 hours ago Breast Imaging Market 2019 - New Research Report at ReportsnReports.com SearchBug, 17 hours ago Glaucoma Therapeutic Pipeline Companies and Drugs Review H1 2015 Report at RnRMarketResearch.com Town Hall, 1 day ago
Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Dublin, Jan. 23, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/j97xjt/video ) has announced the addition of the " " report to their offering. Video communication has been the topic of fascination ...Reliance Trust, 3 days ago Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 Review Seeker, 4 days ago Microbiology Testing/Clinical Microbiology Market by Product: Global Forecast to 2019 companiesandmarkets.com, 1 week ago Global Video Telemedicine Market Industry Analysis 2014-2020: Cardiology, Dermatology, Neurology, Orthopedics, Oncology, Pathology, Radiology, Gynecology, & Dentistry Individual.com, 1 week ago
BIND Therapeutics Amends Credit Facility from Hercules Technology III, L.P. to Accelerate Accurin Pipeline Growth
. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM The capital provided by this financing strengthens our financial resources and provides the flexibility to advance ...Pettinga Financial Advisors, 3 days ago BIND Therapeutics : Founder Publishes Nanotechnology Article in the Journal of the American Medical Association 4 Traders, 4 days ago BIND Therapeutics : Amends Credit Facility from Hercules Technology III, L.P. to Accelerate Accurin Pipeline Growth 4 Traders, 3 days ago BIND Therapeutics (BIND) Co-Founder Publishes Nanotechnology Article In JAMA 1/22/2015 ClinicSpace, 4 days ago
Transparency Market Research Report Added "Clostridium Diagnostics Market" to its database. Albany, NY -- (ReleaseWire) -- 01/23/2015 -- Clostridium is a gram-positive bacteria which belongs to phylum Firmicutes. It's an obligate anaerobe capable ...Digital Journal, 3 days ago Analysis of Hepatitis C Market - Global Industry Segment and Forecasts 2012 - 2018 Digital Journal, 5 days ago Research Report on Imaging Biomarkers Market - Global Analysis and Industry Forecast, 2013 - 2019 Digital Journal, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!